T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.62B |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$1.61B |
| 3 |
Amazon
AMZN
|
+$1.18B |
| 4 |
Lam Research
LRCX
|
+$1.17B |
| 5 |
Las Vegas Sands
LVS
|
+$1.01B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Yum! Brands
YUM
|
+$1.4B |
| 2 |
Apple
AAPL
|
+$1.26B |
| 3 |
Tesla
TSLA
|
+$1.13B |
| 4 |
JPMorgan Chase
JPM
|
+$1.11B |
| 5 |
Morgan Stanley
MS
|
+$1.1B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.93% |
| 2 | Healthcare | 16.29% |
| 3 | Consumer Discretionary | 15.16% |
| 4 | Financials | 15.14% |
| 5 | Communication Services | 9.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Innospec
IOSP
$2.31B
| $42.9M | 0.01% |
560,470
+39,659
| +8% | +$2.97M |
|
952
Hershey
HSY
$37B
| $42.9M | 0.01% |
460,773
-9,294
| -2% | -$867K |
|
|
VSM
953
DELISTED
Versum Materials, Inc.
VSM
| $42.9M | 0.01% |
1,153,927
+5,508
| +0.5% | +$210K |
|
954
Iovance Biotherapeutics
IOVA
$3.05B
| $42.1M | 0.01% |
3,292,287
+1,546,143
| +89% | +$22.6M |
|
|
SASR
955
DELISTED
Sandy Spring Bancorp Inc
SASR
| $42.1M | 0.01% |
1,026,160
+10,772
| +1% | +$441K |
|
956
Bio-Rad Laboratories Class A
BIO
$9.68B
| $41.8M | 0.01% |
144,839
+5,690
| +4% | +$1.57M |
|
957
First Bancorp
FBNC
$2.72B
| $41.5M | 0.01% |
1,015,011
+171,668
| +20% | +$6.8M |
|
|
HI
958
DELISTED
Hillenbrand
HI
| $41.5M | 0.01% |
879,450
-9,502
| -1% | -$446K |
|
959
Consolidated Edison
ED
$39.9B
| $41.1M | 0.01% |
527,617
+10,700
| +2% | +$817K |
|
960
Winmark
WINA
$1.26B
| $41M | 0.01% |
276,329
+1,404
| +0.5% | +$192K |
|
961
Cummins
CMI
$87.8B
| $41M | 0.01% |
308,017
-83
| -0% | -$12.4K |
|
962
Digital Realty Trust
DLR
$73.1B
| $40.9M | 0.01% |
366,499
+4,245
| +1% | +$450K |
|
|
SNV
963
DELISTED
Synovus
SNV
| $40.8M | 0.01% |
772,009
-136,526
| -15% | -$7.26M |
|
964
Middlesex Water
MSEX
$1.1B
| $40.7M | 0.01% |
965,751
+357,837
| +59% | +$14.8M |
|
|
EGN
965
DELISTED
Energen
EGN
| $40.7M | 0.01% |
559,222
+109,635
| +24% | +$7.19M |
|
|
GAP
966
The Gap Inc
GAP
$7.29B
| $40.6M | 0.01% |
1,254,819
+440,705
| +54% | +$13.6M |
|
967
Copart
CPRT
$26.8B
| $40.6M | 0.01% |
2,872,292
+664,124
| +30% | +$9M |
|
968
Welltower
WELL
$166B
| $40.4M | 0.01% |
644,593
| – | – |
|
|
PRTY
969
DELISTED
Party City Holdco Inc.
PRTY
| $40.3M | 0.01% |
2,642,191
-12,264
| -0.5% | -$188K |
|
970
DXC Technology
DXC
$1.71B
| $40.1M | 0.01% |
497,156
-95,611
| -16% | -$8.22M |
|
|
XL
971
DELISTED
XL Group Ltd.
XL
| $39.9M | 0.01% |
713,614
-6,423,945
| -90% | -$358M |
|
972
Devon Energy
DVN
$48.8B
| $39.9M | 0.01% |
906,728
-895,754
| -50% | -$34.7M |
|
|
CCF
973
DELISTED
Chase Corporation
CCF
| $39.8M | 0.01% |
339,025
+4,866
| +1% | +$564K |
|
|
NEX
974
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $39.5M | 0.01% |
2,888,910
+1,540,127
| +114% | +$23.1M |
|
975
Theravance Biopharma
TBPH
$878M
| $39.5M | 0.01% |
1,740,780
-604,415
| -26% | -$14.4M |
|
Similar funds
T. Rowe Price Associates's Q2 2018 Portfolio in Review
As of Q2 2018, T. Rowe Price Associates held 2,648 positions worth $654B, up 4% from $629B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2018 filing shows 98 new, 1,625 increased, 741 reduced and 68 closed positions. Its largest new stake was Evergy: 16,595,898 shares worth $932M. The largest sale was Yum! Brands, an estimated $1.4B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2018 buy was Evergy: 16,595,898 shares worth $932M.
- T. Rowe Price Associates added most to Meta Platforms (Facebook) in Q2 2018, an estimated $1.62B increase.
- T. Rowe Price Associates's biggest Q2 2018 reduction was Yum! Brands, cutting an estimated $1.4B.
- T. Rowe Price Associates fully exited CSRA Inc. in Q2 2018, selling an estimated $912M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $654B portfolio in Q2 2018.
- T. Rowe Price Associates opened 98 new positions and closed 68 in Q2 2018.
- T. Rowe Price Associates's portfolio value rose 4% quarter-over-quarter to $654B.
Based on T. Rowe Price Associates's 13F filing for Q2 2018, filed 14 Aug 2018.